Actions

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q3 FY25
Investor Presentation
Q2 FY25
Investor Presentation
Q4 FY24
Investor Presentation
Q4 FY24
Investor Presentation
Q4 FY22
Investor Presentation
Q3 FY21
Ajooni Biotech Ltd (AJOONI) is currently trading at 3.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Ajooni Biotech Limited specializes in PURE VEG. animal healthcare solutions, prominently featured in the Indian cattle feed sector. The company is expanding its production capacity, with a 70,000 MTPA increase planned in its cattle feed and supplement feed operations, reflecting its strategic focus on scaling up supply capabilities. Ajooni has established significant strategic partnerships and repeat contracts with leading dairy entities, reinforcing its status as a key player in the agricultural feed supply chain. Emerging international market presence with ongoing exports to countries like Bangladesh and Nepal, and plans to explore further Asian markets signal its growth ambitions.
Over the past 52 weeks, Ajooni Biotech Ltd has traded between a low of ₹3.40 and a high of ₹5.94. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Ajooni Biotech Ltd has a market capitalization of approximately 59.25. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Ajooni Biotech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 14.96 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 59.25 Cr, Ajooni Biotech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Ajooni Biotech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Ajooni Biotech Ltd is 14.96. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Bearish
3
Neutral
3
Bullish
8
Bearish
34
Neutral
3
Bullish
9
Bearish
31
Neutral
0
Bullish
1
Bearish
3
Neutral
3
Bullish
8
Bearish
3
Neutral
3
Bullish
8
Bearish
31
Neutral
0
Bullish
1
Bearish
31
Neutral
0
Bullish
1
Bearish
31
Neutral
0
Bullish
1
Pharmaceuticals & Biotechnology
Pharmaceuticals
59 Cr
Low Risk
15.0
37.7
0.3
0.7
5.94
3.40
Sales CAGR
Profit CAGR
ROE
ROCE